Cationic liposome-mediated RNA transfection
- PMID: 2762315
- PMCID: PMC297778
- DOI: 10.1073/pnas.86.16.6077
Cationic liposome-mediated RNA transfection
Abstract
We have developed an efficient and reproducible method for RNA transfection, using a synthetic cationic lipid, N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA), incorporated into a liposome (lipofectin). Transfection of 10 ng to 5 micrograms of Photinus pyralis luciferase mRNA synthesized in vitro into NIH 3T3 mouse cells yields a linear response of luciferase activity. The procedure can be used to efficiently transfect RNA into human, rat, mouse, Xenopus, and Drosophila cells. Using the RNA/lipofectin transfection procedure, we have analyzed the role of capping and beta-globin 5' and 3' untranslated sequences on the translation efficiency of luciferase RNA synthesized in vitro. Following transfection of NIH 3T3 cells, capped mRNAs with beta-globin untranslated sequences produced at least 1000-fold more luciferase protein than mRNAs lacking these elements.
Similar articles
-
Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.Acta Med Okayama. 1997 Jun;51(3):149-54. doi: 10.18926/AMO/30793. Acta Med Okayama. 1997. PMID: 9227794
-
Efficient lipid-mediated transfection of DNA into primary rat hepatocytes.In Vitro Cell Dev Biol Anim. 1995 May;31(5):347-51. doi: 10.1007/BF02634283. In Vitro Cell Dev Biol Anim. 1995. PMID: 7633672
-
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA.Biochim Biophys Acta. 1998 Mar 2;1369(2):320-34. doi: 10.1016/s0005-2736(97)00238-1. Biochim Biophys Acta. 1998. PMID: 9518670
-
In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes.Biochim Biophys Acta. 1996 Apr 10;1306(1):55-62. doi: 10.1016/0167-4781(95)00217-0. Biochim Biophys Acta. 1996. PMID: 8611625
-
In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits.Int J Pharm. 2004 Jul 8;278(2):255-62. doi: 10.1016/j.ijpharm.2004.03.013. Int J Pharm. 2004. PMID: 15196630
Cited by
-
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV).Virol J. 2024 May 31;21(1):124. doi: 10.1186/s12985-024-02397-9. Virol J. 2024. PMID: 38822328 Free PMC article. Review.
-
Cancer mRNA vaccines: clinical advances and future opportunities.Nat Rev Clin Oncol. 2024 Jul;21(7):489-500. doi: 10.1038/s41571-024-00902-1. Epub 2024 May 17. Nat Rev Clin Oncol. 2024. PMID: 38760500 Review.
-
Assembling the RNA therapeutics toolbox.Med Rev (2021). 2024 Mar 20;4(2):110-128. doi: 10.1515/mr-2023-0062. eCollection 2024 Apr. Med Rev (2021). 2024. PMID: 38680684 Free PMC article. Review.
-
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.Int J Biol Sci. 2024 Mar 17;20(6):2111-2129. doi: 10.7150/ijbs.87741. eCollection 2024. Int J Biol Sci. 2024. PMID: 38617529 Free PMC article. Review.
-
Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine.J Dev Biol. 2023 Dec 20;12(1):1. doi: 10.3390/jdb12010001. J Dev Biol. 2023. PMID: 38535481 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases